These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21919619)

  • 21. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: serologic tests.
    Jones LM; García-Carrillo C; Alton GG
    Am J Vet Res; 1973 Feb; 34(2):199-202. PubMed ID: 4631096
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of green fluorescent protein as a marker for Brucella vaccines.
    Chacón-Díaz C; Muñoz-Rodríguez M; Barquero-Calvo E; Guzmán-Verri C; Chaves-Olarte E; Grilló MJ; Moreno E
    Vaccine; 2011 Jan; 29(3):577-82. PubMed ID: 21056079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted prevention of brucellosis in cattle, sheep, and goats in the Russian Federation.
    Sklyarov O; Shumilov K; Klimanov A; Denisov A
    Vaccine; 2010 Oct; 28 Suppl 5():F54-8. PubMed ID: 20362202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Designing vaccines against cattle brucellosis.
    Shumilov KV; Sklyarov O; Klimanov A
    Vaccine; 2010 Oct; 28 Suppl 5():F31-4. PubMed ID: 20362619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model.
    Surendran N; Zimmerman K; Seleem MN; Sriranganathan N; Boyle SM; Hiltbold EM; Lawler H; Heid B; Witonsky SG
    Vaccine; 2010 Oct; 28(43):7009-15. PubMed ID: 20727395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and trial of vaccines against
    Lalsiamthara J; Lee JH
    J Vet Sci; 2017 Aug; 18(S1):281-290. PubMed ID: 28859268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice.
    Estevan M; Gamazo C; Grilló MJ; Del Barrio GG; Blasco JM; Irache JM
    Vaccine; 2006 May; 24(19):4179-87. PubMed ID: 16481077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Trials of the use of live vaccines against brucellosis and listeriosis in farm animals].
    Titov VV
    Arch Exp Veterinarmed; 1980; 34(1):115-8. PubMed ID: 6774688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
    Da Costa Martins R; Irache JM; Blasco JM; Muñoz MP; Marín CM; Jesús Grilló M; Jesús De Miguel M; Barberán M; Gamazo C
    Vaccine; 2010 Apr; 28(17):3038-46. PubMed ID: 19887131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against Brucella.
    Nicoletti P
    Adv Biotechnol Processes; 1990; 13():147-68. PubMed ID: 2185782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The advances in brucellosis vaccines.
    Hou H; Liu X; Peng Q
    Vaccine; 2019 Jul; 37(30):3981-3988. PubMed ID: 31176541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human exposure to Brucella abortus strain RB51--Kansas, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(9):172-5. PubMed ID: 9518281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis.
    Pandey A; Cabello A; Akoolo L; Rice-Ficht A; Arenas-Gamboa A; McMurray D; Ficht TA; de Figueiredo P
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004572. PubMed ID: 27537413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brucella abortus strain RB51 vaccine: its advantages and risks.
    Kahler SC
    J Am Vet Med Assoc; 1998 Jul; 213(1):12, 22. PubMed ID: 9656011
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
    Pasquevich KA; García Samartino C; Coria LM; Estein SM; Zwerdling A; Ibañez AE; Barrionuevo P; Oliveira FS; Carvalho NB; Borkowski J; Oliveira SC; Warzecha H; Giambartolomei GH; Cassataro J
    J Immunol; 2010 May; 184(9):5200-12. PubMed ID: 20351187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.